TAYLOR WARD: Open Payments
NPI 1386200954 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $709
Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $452 |
| GENZYME CORPORATION | 3 | $63 |
| BioCryst US Sales Co., LLC | 2 | $56 |
| CSL Behring | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| LEO Pharma Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: TEZSPIRE, AIRSUPRA, DUPIXENT, ORLADEYO, FASENRA, ANZUPGO, Xolair, Rhapsido.
Industry payments across AZ — which companies pay providers there.
